Hercules Capital, Inc. EBITDA History
HTGC|6 years of SEC 10-K data (FY2020-FY2025)
$337,000 in FY2025 with a 5-year CAGR of -4.1%.
Improved from $190,000 to $337,000 over the past 2 years.
Improved from $190,000 to $337,000 over the past 2 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
- 3-Year CAGR
- +18.2%
- 5-Year CAGR
- -4.1%
- 10-Year CAGR
- -
EBITDA Trend
Key Insights
- 5-year CAGR of -4.1%, indicating a declining trend.
- In FY2025, ebitda decreased 27.7% year-over-year.
- Peak ebitda was recorded in FY2024.
- Lowest ebitda in the period was in FY2023.
Annual Data
| Year | EBITDA | YoY Growth |
|---|---|---|
| FY2025 | $337.0K | -27.7% |
| FY2024 | $466.0K | +145.3% |
| FY2023 | $190.0K | -6.9% |
| FY2022 | $204.0K | -35.6% |
| FY2021 | $317.0K | -23.6% |
| FY2020 | $415.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026